Particularly noteworthy is that in patients with both type 2 diabetes and MASLD, after 24 weeks of treatment with a 10 mg dose of efinopegdutide, liver fat content reduced by 72.7%, a result that is superior to the 42.3% reduction achieved with a 1 mg dose of semaglutide, despite a similar overall weight loss being observed with the two interventions
Semaglutide can treat: Excess fat in the stomach, thighs, buttocks, arms, and more High blood sugar Poor cardiac health Obesity When paired with lifestyle adjustments, such as a healthier diet and increased activity, semaglutide has transformational effects
This will include a combination of the following: Weekly semaglutide injections These can be done at home
This finding could pave the way for more targeted treatments that go beyond blood sugar management to directly address kidney deterioration and cardiovascular risks in diabetes
Proteomic characterization of middle ear fluid confirms neutrophil extracellular traps as a predominant innate immune response in chronic otitis media
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD , 34(8), 19761983